Patrick J Sinko

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Oxide Nanoparticles

Vascular Endothelial Growth Factor

Top Venues

Antioxidants (Basel, Switzerland)

Drug delivery and translational research

This page only lists publications with an associated author ORCID identifier.

Publications

Tomas L Roldan, Shike Li, Christophe Guillon, Ned D Heindel, Jeffrey D Laskin, In Heon Lee, Dayuan Gao, Patrick J Sinko
Optimizing Nanosuspension Drug Release and Wound Healing Using a Design of Experiments Approach: Improving the Drug Delivery Potential of NDH-4338 for Treating Chemical Burns. Pharmaceutics 16 (4) (2024)
Tomas L Roldan, Shike Li, Christophe Guillon, Ned D Heindel, Jeffrey D Laskin, In Heon Lee, Dayuan Gao, Patrick J Sinko
Optimizing Nanosuspension Drug Release and Wound Healing Using a Design of Experiments Approach: Improving the Drug Delivery Potential of NDH-4338 for Treating Chemical Burns. Pharmaceutics 16 (4) (2024)
Simarjot Kaur Sandhu, Suneel Kumar, Jayant Raut, Mandeep Singh, Sandeep Kaur, Garima Sharma, Tomas L Roldan, Sonia Trehan, Jennifer Holloway, Gabriella Wahler, Jeffrey D Laskin, Patrick J Sinko, Francois Berthiaume, Bozena Michniak-Kohn, Praveen Rishi, Narayanan Ganesh, Indu Pal Kaur
Systematic Development and Characterization of Novel, High Drug-Loaded, Photostable, Curcumin Solid Lipid Nanoparticle Hydrogel for Wound Healing. Antioxidants (Basel, Switzerland) 10 (5) (2021)
Firas Al-Zubaydi, Dayuan Gao, Dipti Kakkar, Shike Li, Jennifer Holloway, Zoltan Szekely, Nancy Chan, Shicha Kumar, Hatem E Sabaawy, Susan Love, Patrick J Sinko
Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy. Drug delivery and translational research (2021)
Peiming Chen, Xiaoping Zhang, Alessandro Venosa, In Heon Lee, Daniel Myers, Jennifer A Holloway, Robert K Prud'homme, Dayuan Gao, Zoltan Szekely, Jeffery D Laskin, Debra L Laskin, Patrick J Sinko
A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages. Pharmaceutics 12 (3) (2020)